` Comparison: 2256 vs VRTX - Alpha Spread

2256
vs
VRTX

Over the past 12 months, Abbisko Cayman Ltd has significantly outperformed VRTX, delivering a return of +54% compared to the VRTX's 9% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
2256
VRTX
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

Intrinsic Value
6.91 HKD
Overvaluation 44%
Intrinsic Value
Price
VRTX Intrinsic Value
382.8 USD
Overvaluation 18%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Abbisko Cayman Ltd
HKEX:2256
12.32 HKD
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
466.1 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
2256, VRTX

2256
VRTX
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Abbisko Cayman Ltd
Revenue
Vertex Pharmaceuticals Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
2256, VRTX

2256
VRTX
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Abbisko Cayman Ltd
HKEX:2256
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

Abbisko Cayman Ltd
100%
VRTX
86.2%

Operating Margin

Abbisko Cayman Ltd
19.6%
VRTX
39%

Net Margin

Abbisko Cayman Ltd
9%
VRTX
32.9%

FCF Margin

Abbisko Cayman Ltd
20.3%
VRTX
26.6%

ROE

Abbisko Cayman Ltd
2.8%
VRTX
22.5%

ROA

Abbisko Cayman Ltd
2.6%
VRTX
16.4%

ROIC

Abbisko Cayman Ltd
38.5%
VRTX
26.9%

ROCE

Abbisko Cayman Ltd
6.1%
VRTX
23%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
2256, VRTX

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
2256, VRTX

Loading
2256
VRTX
Difference
www.alphaspread.com

Performance By Year
2256, VRTX

Loading
2256
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 2256 to other stocks
PNEXF
Pharnext SCA
More expensive
vs Abbisko Cayman Ltd
ABBV
Abbvie Inc
Cheaper
vs Abbisko Cayman Ltd
AMGN
Amgen Inc
Cheaper
vs Abbisko Cayman Ltd
GILD
Gilead Sciences Inc
Cheaper
vs Abbisko Cayman Ltd
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett